glp 1 agonist gila monster Why Useless Knowledge Can Be So Useful simplify_drugs Exenatide is a synthetic

Cardiovascular, Mortality, and Kidney Outcomes With GLP-1 Receptor Agonists in Patients With Type 2 Diabetes: A Systematic Review and Meta-Analysis of Cardiovascular Outcome Trials

however, evidence investigating long-lasting and mechanistic effects of combined amylin and GLP-1 pharmacotherapy is still lacking

doi:10.1158/1078-0432.CCR-21-0715 136

A true breakthrough: The eye-opening potential of GLP-1 agonists to treat heart, kidney disease in addition to obesity Science , a popular journal published by the American Association for the Advancement of Science (AAAS), has announced that ongoing research into the benefits of GLP-1 agonists such as semaglutide is its 2023 Breakthrough of the Year

NPJ Parkinsons Dis (2020) 6:15

Nonetheless, residual effects on gastric emptying could still produce significant gastrointestinal adverse effects in patients treated with long-acting GLP-RAs (167)